Patients lowering 'bad' cholesterol (USA)

The percentage of U.S. patients lowering their elevated "bad" cholesterol to within target levels nearly doubled in the last decade, researchers found. Dr. David D. Waters, an emeritus professor at University of California in San Francisco who was the lead author of the study, said the Lipid Treatment Assessment Project surveyed nearly 10,000 patients - average age 62 - from nine countries undergoing cholesterol-lowering and management efforts. Low-density lipoprotein, or LDL, is known as "bad" cholesterol because it's associated with increased cardiovascular risk. The study was published in the journal Circulation: Journal of the American Heart Association - UPI